Indeed, high TLR2 expression is associated with poor response to chemotherapy in pancreatic [77] and breast cancer [37] patients, suggesting that it could represent a good target to improve chemotherapy efficacy in OSA patients as well. Here, TLR2 is linked to breast cancer.